XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue - Summary of Revenues Disaggregated by Product Classification and Reportable Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Disaggregation Of Revenue [Line Items]        
Total revenue $ 23,873 $ 26,883 $ 81,165 $ 72,321
Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 12,084 11,987 33,969 33,731
Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 8,796 12,398 38,182 30,767
Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,993 2,498 9,014 7,823
Operating Segments [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 23,873 26,883 81,165 72,321
Operating Segments [Member] | Medical Device [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 16,755 20,514 60,858 54,222
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 5,493 5,763 15,464 16,240
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 7,752 4,752 23,135 20,365
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,466 2,353 7,212 7,215
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 1,044 7,646 15,047 10,402
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 7,118 6,369 20,307 18,099
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 6,591 6,224 18,505 17,491
Operating Segments [Member] | In Vitro Diagnostics [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue $ 527 $ 145 $ 1,802 $ 608